{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "marketState": "PRE", "exchange": "NMS", "regularMarketChangePercent": 0.2686441, "regularMarketPrice": 78.38, "firstTradeDateMilliseconds": 696090600000, "priceHint": 2, "earningsTimestamp": 1682627400, "earningsTimestampStart": 1690801140, "earningsTimestampEnd": 1691150400, "trailingAnnualDividendRate": 2.94, "trailingPE": 17.73303, "trailingAnnualDividendYield": 0.037610337, "epsTrailingTwelveMonths": 4.42, "epsForward": 7.18, "epsCurrentYear": 6.78, "priceEpsCurrentYear": 11.560472, "sharesOutstanding": 1247350016, "bookValue": 16.825, "fiftyDayAverage": 81.1682, "fiftyDayAverageChange": -2.7882004, "fiftyDayAverageChangePercent": -0.034350898, "twoHundredDayAverage": 77.2342, "twoHundredDayAverageChange": 1.1457977, "twoHundredDayAverageChangePercent": 0.014835368, "marketCap": 97767292928, "forwardPE": 10.916434, "priceToBook": 4.6585436, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.5 - Buy", "tradeable": false, "cryptoTradeable": false, "shortName": "Gilead Sciences, Inc.", "longName": "Gilead Sciences, Inc.", "messageBoardId": "finmb_29002", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "preMarketChange": 0.87000275, "preMarketChangePercent": 1.1099806, "preMarketTime": 1684230624, "preMarketPrice": 79.25, "regularMarketChange": 0.20999908, "regularMarketTime": 1684180804, "regularMarketDayHigh": 78.4, "regularMarketDayRange": "77.83 - 78.4", "regularMarketDayLow": 77.83, "regularMarketVolume": 2612089, "regularMarketPreviousClose": 78.17, "bid": 0.0, "ask": 0.0, "bidSize": 12, "askSize": 11, "fullExchangeName": "NasdaqGS", "financialCurrency": "USD", "regularMarketOpen": 78.07, "averageDailyVolume3Month": 5396701, "averageDailyVolume10Day": 4523250, "fiftyTwoWeekLowChange": 21.21, "fiftyTwoWeekLowChangePercent": 0.37099877, "fiftyTwoWeekRange": "57.17 - 89.74", "fiftyTwoWeekHighChange": -11.360001, "fiftyTwoWeekHighChangePercent": -0.12658793, "fiftyTwoWeekLow": 57.17, "fiftyTwoWeekHigh": 89.74, "dividendDate": 1687996800, "displayName": "Gilead Sciences", "symbol": "GILD"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "333 Lakeside Drive", "city": "Foster City", "state": "CA", "zip": "94404", "country": "United States", "phone": "650 574 3000", "fax": "650 522 5853", "website": "https://www.gilead.com", "industry": "Drug Manufacturers\u2014General", "industryDisp": "Drug Manufacturers\u2014General", "sector": "Healthcare", "longBusinessSummary": "Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.", "fullTimeEmployees": 17000, "companyOfficers": [{"maxAge": 1, "name": "Mr. Daniel P.  O'Day", "age": 58, "title": "Chairman & CEO", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 7267338, "fmt": "7.27M", "longFmt": "7,267,338"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 9635551, "fmt": "9.64M", "longFmt": "9,635,551"}}, {"maxAge": 1, "name": "Mr. Andrew D. Dickinson", "age": 52, "title": "Exec. VP & CFO", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": {"raw": 2935112, "fmt": "2.94M", "longFmt": "2,935,112"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 5436829, "fmt": "5.44M", "longFmt": "5,436,829"}}, {"maxAge": 1, "name": "Ms. Deborah H. Telman", "age": 57, "title": "Exec. VP of Corp. Affairs, Gen. Counsel & Corp. Sec.", "yearBorn": 1965, "fiscalYear": 2022, "totalPay": {"raw": 2323080, "fmt": "2.32M", "longFmt": "2,323,080"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Johanna  Mercier", "age": 52, "title": "Chief Commercial Officer", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": {"raw": 3322200, "fmt": "3.32M", "longFmt": "3,322,200"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 3864125, "fmt": "3.86M", "longFmt": "3,864,125"}}, {"maxAge": 1, "name": "Dr. Merdad V. Parsey M.D., Ph.D.", "age": 59, "title": "Chief Medical Officer", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": {"raw": 3074714, "fmt": "3.07M", "longFmt": "3,074,714"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 3047349, "fmt": "3.05M", "longFmt": "3,047,349"}}, {"maxAge": 1, "name": "Ms. Sandra  Patterson", "age": 55, "title": "Sr. VP, Corp. Controller & Principal Accounting Officer", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Jacquie  Ross C.F.A.", "title": "VP of Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Jyoti K. Mehra", "age": 46, "title": "Exec. VP of HR", "yearBorn": 1976, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Michael  Quigley Ph.D.", "title": "Sr. VP of Research Biology", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Linda Slanec Higgins Ph.D.", "age": 60, "title": "Sr. VP & Head of External Innovation", "yearBorn": 1962, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 2, "boardRisk": 5, "compensationRisk": 3, "shareHolderRightsRisk": 1, "overallRisk": 1, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}